Progyny Inc
NASDAQ:PGNY

Watchlist Manager
Progyny Inc Logo
Progyny Inc
NASDAQ:PGNY
Watchlist
Price: 18.12 USD 1.06% Market Closed
Market Cap: $1.5B

EV/EBIT

12.1
Current
54%
Cheaper
vs 3-y median of 26.2

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
12.1
=
Enterprise Value
$1.2B
/
EBIT
$90.9m

Enterprise Value to EBIT (EV/EBIT) ratio compares a company`s total enterprise value to its earnings before interest and taxes. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBIT
12.1
=
Enterprise Value
$1.2B
/
EBIT
$90.9m

Valuation Scenarios

Progyny Inc is trading below its 3-year average

If EV/EBIT returns to its 3-Year Average (26.2), the stock would be worth $39.31 (117% upside from current price).

Statistics
Positive Scenarios
4/4
Maximum Downside
No Downside Scenarios
Maximum Upside
+504%
Average Upside
186%
Scenario EV/EBIT Value Implied Price Upside/Downside
Current Multiple 12.1 $18.12
0%
3-Year Average 26.2 $39.31
+117%
5-Year Average 73.1 $109.5
+504%
Industry Average 19.2 $28.83
+59%
Country Average 19.6 $29.39
+62%

Forward EV/EBIT
Today’s price vs future ebit

Today's Enterprise Value EBIT Forward EV/EBIT
$1.2B
/
Jan 2026
$90.9m
=
12.1
Current
$1.2B
/
Dec 2026
$192.4m
=
6
Forward
$1.2B
/
Dec 2027
$217.4m
=
5.3
Forward
$1.2B
/
Dec 2028
$288.8m
=
4
Forward

Forward EV/EBIT shows whether today’s EV/EBIT still looks high or low once future ebit are taken into account.

Peer Comparison

All Multiples
EV/EBIT
P/E
All Countries
Close
Market Cap EV/EBIT P/E
US
Progyny Inc
NASDAQ:PGNY
1.5B USD 12.1 25.3
US
UnitedHealth Group Inc
NYSE:UNH
294.1B USD 0 24.4
US
Anthem Inc
LSE:0HG8
83.9B USD 0 14.8
US
Elevance Health Inc
NYSE:ELV
71.3B USD 0 12.6
US
Humana Inc
NYSE:HUM
24.7B USD 0 20.8
US
Centene Corp
NYSE:CNC
18.8B USD 0 -2.8
US
Molina Healthcare Inc
NYSE:MOH
7.6B USD 4.3 16.1
US
Healthequity Inc
NASDAQ:HQY
7.3B USD 24 34
US
Magellan Health Inc
F:MAH1
2.2B EUR 38.5 8.5
BR
Odontoprev SA
BOVESPA:ODPV3
8.6B BRL 10.8 14.8
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
5.9B BRL 5.9 -41.4
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
Progyny Inc
NASDAQ:PGNY
Average EV/EBIT: 16
12.1
47%
0.3
US
UnitedHealth Group Inc
NYSE:UNH
Not Available N/A N/A
US
A
Anthem Inc
LSE:0HG8
Not Available N/A N/A
US
Elevance Health Inc
NYSE:ELV
Not Available N/A N/A
US
Humana Inc
NYSE:HUM
Not Available N/A N/A
US
Centene Corp
NYSE:CNC
Not Available N/A N/A
US
Molina Healthcare Inc
NYSE:MOH
4.3
10%
0.4
US
Healthequity Inc
NASDAQ:HQY
24
N/A N/A
US
M
Magellan Health Inc
F:MAH1
38.5
N/A N/A
BR
Odontoprev SA
BOVESPA:ODPV3
10.8
4%
2.7
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
5.9
25%
0.2
P/E Multiple
Earnings Growth PEG
US
Progyny Inc
NASDAQ:PGNY
Average P/E: 19
25.3
35%
0.7
US
UnitedHealth Group Inc
NYSE:UNH
24.4
22%
1.1
US
A
Anthem Inc
LSE:0HG8
14.8
10%
1.5
US
Elevance Health Inc
NYSE:ELV
12.6
10%
1.3
US
Humana Inc
NYSE:HUM
20.8
38%
0.5
US
Centene Corp
NYSE:CNC
Negative Multiple: -2.8 N/A N/A
US
Molina Healthcare Inc
NYSE:MOH
16.1
14%
1.1
US
Healthequity Inc
NASDAQ:HQY
34
35%
1
US
M
Magellan Health Inc
F:MAH1
8.5
N/A N/A
BR
Odontoprev SA
BOVESPA:ODPV3
14.8
4%
3.7
BR
Hapvida Participacoes e Investimentos SA
BOVESPA:HAPV3
Negative Multiple: -41.4 N/A N/A

Market Distribution

Lower than 76% of companies in the United States of America
Percentile
24rd
Based on 8 638 companies
24rd percentile
12.1
Low
0 — 13.6
Typical Range
13.6 — 27.8
High
27.8 —
Distribution Statistics
the United States of America
Min 0
30th Percentile 13.6
Median 19.6
70th Percentile 27.8
Max 1 826 183.2

Progyny Inc
Glance View

In a world where the concept of family is continually evolving, Progyny Inc. emerges as a pioneer, reshaping the landscape of fertility and family-building benefits. Founded with a mission to offer comprehensive fertility solutions, the company leverages a unique combination of personalized concierge service and cutting-edge technology to meet the growing demand for reproductive health services. Progyny's role in the industry is substantial, providing a suite of tailored benefits that include fertility treatments, egg freezing, genetic testing, and support services. Through its proprietary Smart Cycle plan, Progyny stands apart by integrating these services into a single, streamlined benefits package, reducing complexities and elevating the experience for patients and employers alike. The heart of Progyny's business model lies in its collaboration with employers, offering them the opportunity to include comprehensive fertility benefits as part of their health packages. By doing so, Progyny opens the door for companies to attract and retain talent in a competitive workforce, ensuring employees have access to vital reproductive assistance. The company generates revenue by partnering with these employers, who pay for the fertility benefits as part of their employee health plans. This innovative approach not only ensures recurring income for Progyny but also aligns the company’s success with positive health outcomes for its clients. As more organizations recognize the value in supporting employees' family-building journeys, Progyny’s influence and relevance in the market continue to grow, reinforcing its standing as a leader in fertility solutions.

PGNY Intrinsic Value
37.84 USD
Undervaluation 52%
Intrinsic Value
Price $18.12
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett